Eisai Announces Approval of Partial Change to Label for Dosage and Administration of Aricept for Treatment of Dementia with Lewy Bodies

TOKYO, Nov 29, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced that its application for a partial change to label for Aricept…